In a major win for blood cancer patients in Australia, approval's been granted for a potentially lifesaving therapy to be manufactured locally. A state-of-the-art facility in Melbourne is to join just a handful of sites globally permitted to produce the CAR-T cell therapy Kymriah.
Share





